博济医药：拟减持不超266.7万股的已回购股份

Group 1 - The company, Boji Pharmaceutical (300404.SZ), announced on February 24, 2026, that it will hold the 19th meeting of the fifth board of directors to review a share repurchase plan [1] - The board approved a plan to repurchase shares for the purpose of maintaining company value and shareholder rights, with a maximum repurchase quantity of 2.667 million shares, representing 0.69% of the current total share capital [1]